(PRWEB) August 30, 2012
On April 17, the United States Judicial Panel on Multidistrict Litigation announced that all federal Zoloft lawsuits would be consolidated into a single litigation in a Pennsylvania federal court. Judge Cynthia M. Rufe will hear MDL 2342, this particular multidistrict litigation which involves almost 40 pending actions, in the United States District Court for the District of Eastern Pennsylvania; where more than half of the actions are already pending. These cases, brought on the behalf of families whose babies were born with serious and even life-threatening birth defects, involve mothers who were prescribed and took Zoloft during their pregnancies. Pfizer, the manufacturer of Zoloft, was allegedly negligent in their failure to warn about the dangers involved in taking Zoloft while pregnant. Birth defects that have been associated with the antidepressant include, but are not limited to:
At the time of the consolidation, over 100 Zoloft birth defect lawsuits had been filed in federal court. The reasoning behind consolidating such a vast number of lawsuits into a single multidistrict litigation is to offer consistent rulings in a swift and efficient manner.
The attorneys at d’Oliveira & Associates urge any one who has suffered from the use of Zoloft to contact them immediately and seek the advice of a medical professional. d’Oliveira & Associates are working with some of the leading dangerous drug lawyers in the country who are handling these cases. They want to ensure that all potential Zoloft birth defect clients understand that there is absolutely no fee unless a settlement is reached, or an award is won.
For a free legal consultation, call 1-800-992-6878 or visit their website at Zoloft Lawsuit Lawyer